Thermo Fisher Scientific Inc. (NYSE:TMO)


Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Beginner level

Thermo Fisher Scientific Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Sep 28, 2019 Jun 29, 2019 Mar 30, 2019 Dec 31, 2018 Sep 29, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jul 1, 2017 Apr 1, 2017 Dec 31, 2016 Oct 1, 2016 Jul 2, 2016 Apr 2, 2016 Dec 31, 2015 Sep 26, 2015 Jun 27, 2015 Mar 28, 2015
Short-term obligations and current maturities of long-term obligations 1.16 1.17 4.10 2.40 2.26 1.84 3.09 4.97 3.77 4.93 3.31 4.07 2.73 4.11 5.95 7.88 2.57 7.37 8.04 9.94
Accounts payable 3.29 2.92 2.40 2.63 2.87 2.44 2.45 2.39 2.52 2.01 2.11 2.23 2.02 1.96 2.00 1.99 2.01 1.90 1.96 1.98
Accrued payroll and employee benefits 1.73 1.56 1.40 1.27 1.75 1.48 1.36 1.14 1.62 1.38 1.32 1.13 1.54 1.27 1.23 0.98 1.46 1.33 1.15 1.16
Contract liabilities 1.57 1.66 1.83 1.74 1.44 1.45 1.47 1.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.27 1.33 1.17 1.17 1.06 1.03 0.85 0.84 0.78 0.78 0.80 0.80
Other accrued expenses 2.87 2.99 3.23 2.57 2.61 2.22 2.42 2.39 3.26 2.91 3.01 2.88 3.24 2.59 3.04 3.04 3.32 2.55 2.65 2.52
Current liabilities 10.61% 10.30% 12.95% 10.61% 10.93% 9.43% 10.79% 12.50% 12.44% 12.56% 10.91% 11.47% 10.60% 10.96% 13.08% 14.72% 10.14% 13.94% 14.60% 16.39%
Deferred income taxes 3.75 3.53 3.34 3.86 4.03 4.63 4.69 4.61 4.88 5.60 4.99 5.33 5.57 5.65 5.87 6.27 6.41 7.37 7.50 7.70
Other long-term liabilities 5.55 5.53 5.40 5.48 4.47 4.87 4.82 4.70 4.53 3.37 3.16 3.17 3.43 2.99 3.19 3.16 3.17 3.04 2.86 2.78
Long-term obligations, excluding current maturities 29.25 28.90 28.74 30.24 31.51 32.25 31.96 32.03 33.30 34.35 32.80 32.87 33.49 35.28 27.53 27.13 28.06 24.98 25.53 25.55
Long-term liabilities 38.56% 37.95% 37.49% 39.58% 40.01% 41.74% 41.47% 41.33% 42.72% 43.32% 40.95% 41.36% 42.48% 43.93% 36.59% 36.56% 37.64% 35.39% 35.89% 36.03%
Total liabilities 49.17% 48.25% 50.44% 50.19% 50.94% 51.18% 52.27% 53.83% 55.16% 55.88% 51.86% 52.84% 53.08% 54.89% 49.68% 51.29% 47.78% 49.33% 50.50% 52.42%
Preferred stock, $100 par value; none issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $1 par value 0.74 0.77 0.75 0.78 0.77 0.78 0.78 0.76 0.76 0.76 0.90 0.90 0.90 0.86 0.98 0.96 1.01 1.00 0.98 0.98
Capital in excess of par value 25.80 26.38 25.68 26.57 26.00 26.37 26.01 25.31 25.02 25.21 26.50 26.51 26.44 25.20 28.44 27.75 28.86 28.51 27.93 27.73
Retained earnings 37.84 37.31 35.33 34.96 33.25 32.44 31.09 29.24 28.08 27.59 32.19 31.20 30.34 27.82 30.63 29.07 29.70 28.19 26.77 25.64
Treasury stock at cost -8.97 -7.91 -7.66 -7.99 -6.52 -6.20 -5.65 -5.52 -5.48 -5.54 -6.60 -6.10 -5.02 -4.28 -4.80 -4.72 -2.46 -2.45 -2.37 -2.36
Accumulated other comprehensive items -4.59 -4.80 -4.54 -4.51 -4.44 -4.57 -4.50 -3.61 -3.53 -3.90 -4.85 -5.35 -5.74 -4.49 -4.93 -4.35 -4.88 -4.58 -3.82 -4.41
Shareholders’ equity 50.83% 51.75% 49.56% 49.81% 49.06% 48.82% 47.73% 46.17% 44.84% 44.12% 48.14% 47.16% 46.92% 45.11% 50.32% 48.71% 52.22% 50.67% 49.50% 47.58%
Total liabilities and shareholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (filing date: 2020-02-26), 10-Q (filing date: 2019-11-01), 10-Q (filing date: 2019-08-02), 10-Q (filing date: 2019-05-03), 10-K (filing date: 2019-02-27), 10-Q (filing date: 2018-11-02), 10-Q (filing date: 2018-08-03), 10-Q (filing date: 2018-05-04), 10-K (filing date: 2018-02-28), 10-Q (filing date: 2017-11-03), 10-Q (filing date: 2017-08-04), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-28), 10-Q (filing date: 2016-11-04), 10-Q (filing date: 2016-08-05), 10-Q (filing date: 2016-05-06), 10-K (filing date: 2016-02-25), 10-Q (filing date: 2015-10-30), 10-Q (filing date: 2015-07-31), 10-Q (filing date: 2015-05-01).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Thermo Fisher Scientific Inc.’s current liabilities as a percentage of total liabilities and shareholders’ equity decreased from Q2 2019 to Q3 2019 but then slightly increased from Q3 2019 to Q4 2019.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Thermo Fisher Scientific Inc.’s long-term liabilities as a percentage of total liabilities and shareholders’ equity increased from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Thermo Fisher Scientific Inc.’s total liabilities as a percentage of total liabilities and shareholders’ equity decreased from Q2 2019 to Q3 2019 but then slightly increased from Q3 2019 to Q4 2019.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Thermo Fisher Scientific Inc.’s shareholders’ equity as a percentage of total liabilities and shareholders’ equity increased from Q2 2019 to Q3 2019 but then slightly decreased from Q3 2019 to Q4 2019.